Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Shot in the arm for vaccine without needles and knees without pain

Justin Cooper-White and Mark Kendall
Justin Cooper-White and Mark Kendall

Abstract:
Researchers at The University of Queensland have had success in swapping their white lab coats for boardroom suits, with awards in a prestigious national business plan competition.

Shot in the arm for vaccine without needles and knees without pain

Brisbane | Posted on October 29th, 2010

Teams from the Australian Institute for Bioengineering and Nanotechnology took out the best pitch prize and audience award during the final of UQ Business School's Enterprize competition at the State Library of Queensland.

Professor Mark Kendall's team took out the Women in Technology Award on October 20, after securing 74 per cent of the audience vote while pitching their business concept to an audience, including investors.

The win recognised their work in putting together a business plan to commercialise the needle-free vaccine delivery device Nanopatch.

Nanopatch has been shown in trials to provide a protective immunisation in mice, with less than a hundredth of the dosage used compared to a needle and syringe.

Professor Justin Cooper-White's team won the i.lab award for best pitch, earning a nod from judges who are themselves investors.

The win recognised their work in putting together a business plan to commercialise Dyniform Meniscal Replacement Therapy (Dyniform-MRT).

The team is developing breakthrough technology to repair a torn or injured meniscus in the knee joint.

Dyniform-MRT is yet to undergo preclinical or human clinical trials and the earliest the product would reach the market is 2018.

The two AIBN awards follow months of work in establishing business plans, doing market analysis, preparing competitive advantage and a financial forecasts and enduring in-depth interviews with the panel of five judges.

Prof Kendall said: "Certainly this award provides a form of external validation, not only for the Nanopatch technology as a commercial prospect, but also our commercialisation strategy."

"Our ambition is for Nanopatch to be taken from the current stage of animal model success through the clinic - and on to the market as a next-generation vaccine delivery device, potentially displacing the needle and syringe.

"This progression requires commercialisation and partnership with the right players."

Prof Cooper-White said the best pitch award showed his team was on the right track with both its knee-joint technology and the way it was received in the business and investment fields.
"It gives us a better sense of how good our product is and how competitive we are. It gives us visibility and helps us build momentum with our partnering strategy to take the technology out of the lab and into the wider world."

####

For more information, please click here

Contacts:
Media: Professor Mark Kendall (07 3346 4203, 0431 162 391) or Professor Justin Cooper-White (3346 3858)

Copyright © University of Queensland

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Strength of hair inspires new materials for body armor January 18th, 2017

Self-assembling particles brighten future of LED lighting January 18th, 2017

Dressing a metal in various colors: DGIST research developed a technology to coat metal with several nanometers of semiconducting materials January 17th, 2017

Nanoparticle exposure can awaken dormant viruses in the lungs January 17th, 2017

Academic/Education

Oxford Nanoimaging report on how the Nanoimager, a desktop microscope delivering single molecule, super-resolution performance, is being applied at the MRC Centre for Molecular Bacteriology & Infection November 22nd, 2016

The University of Applied Sciences in Upper Austria uses Deben tensile stages as an integral part of their computed tomography research and testing facility October 18th, 2016

Enterprise In Space Partners with Sketchfab and 3D Hubs for NewSpace Education October 13th, 2016

New Agricultural Research Center Debuts at UCF October 12th, 2016

Nanomedicine

New active filaments mimic biology to transport nano-cargo: A new design for a fully biocompatible motility engine transports colloidal particles faster than diffusion with active filaments January 11th, 2017

Keystone Nano Announces FDA Approval Of Investigational New Drug Application For Ceramide NanoLiposome For The Improved Treatment Of Cancer January 10th, 2017

Captured on video: DNA nanotubes build a bridge between 2 molecular posts: Research may lead to new lines of direct communication with cells January 9th, 2017

Arrowhead Provides Response to New Minority Shareholder Announcement January 7th, 2017

Announcements

Strength of hair inspires new materials for body armor January 18th, 2017

Self-assembling particles brighten future of LED lighting January 18th, 2017

Dressing a metal in various colors: DGIST research developed a technology to coat metal with several nanometers of semiconducting materials January 17th, 2017

Nanoparticle exposure can awaken dormant viruses in the lungs January 17th, 2017

Grants/Awards/Scholarships/Gifts/Contests/Honors/Records

Nanoscale view of energy storage January 16th, 2017

Captured on video: DNA nanotubes build a bridge between 2 molecular posts: Research may lead to new lines of direct communication with cells January 9th, 2017

Researchers produced nitrogen doped bimodal cellular structure activated carbon December 29th, 2016

Nanomechanics Inc. Continues Growth in Revenue and Market Penetration: Leading nanoindentation company reports continued growth in revenues and distribution channels on national and international scales December 27th, 2016

Nanobiotechnology

Nanoscale Modifications can be used to Engineer Electrical Contacts for Nanodevices January 13th, 2017

New active filaments mimic biology to transport nano-cargo: A new design for a fully biocompatible motility engine transports colloidal particles faster than diffusion with active filaments January 11th, 2017

Keystone Nano Announces FDA Approval Of Investigational New Drug Application For Ceramide NanoLiposome For The Improved Treatment Of Cancer January 10th, 2017

Captured on video: DNA nanotubes build a bridge between 2 molecular posts: Research may lead to new lines of direct communication with cells January 9th, 2017

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project